Descriptive data of NHL/CLL cases subgroups included in the study.
| Parameter | DLBCL (N=44) | FL (N=22) | MCL (N=10) | CLL (N=14) | HCL (N=12) |
|---|---|---|---|---|---|
| Age, yr (mean±SD) | 43.5±10.8 | 50.6±11.5 | 48±4.3 | 55±8.8 | 52±14.2 |
| Gender (male/female) | 26/18 | 8/14 | 8/2 | 6/8 | 6/6 |
| Hb, g/dL (mean±SD) | 12.1±1.2 | 11.8±0.9 | 11.8±0.8 | 11.6±0.3 | 10.2±1.4 |
| Platelets, cells×103/mL(mean±SD) | 313±76.6 | 245.8±73.8 | 225.6±51.7 | 159.2±9.9 | 106.5±20.3 |
| LDH, mg/dL (mean±SD) | 555.3±159.6 | 613.8±148.1 | 730±105.1 | 434.7±146.9 | 316.3±44.4 |
| Lymphocyte count, cells×103/mL (median and IQ range) | 2.2 (2.5) | 2 (2.4) | 2.6 (2.4) | 19 (22) | 2.2(2.5) |
| B-symptoms, N (%) | 18 (40.9) | 8 (36.4) | 2 (20) | 4 (28.6) | 8 (66.7) |
| LNS, N (%) | 44 (100) | 22 (100) | 10 (100) | 10 (71.4) | 2(16.7) |
| HSM, N (%) | 20 (45.5) | 10 (45.5) | 2 (20) | 8 (57.1) | 10 (83.3) |
| Stage, N (%) | |||||
| Stage1 | 8 (18.2) | 2 (9.1) | 0 (0) | 0 (0) | 0 (0) |
| Stage 2 | 14 (31.8) | 2 (9.1) | 0 (0) | 0 (0) | 0 (0) |
| Stage 3 | 6 (13.6) | 4 (18.2) | 4 (40) | 0 (0) | 0 (0) |
| Stage 4 | 16 (36.4) | 14 (63.6) | 6 (60) | 14 (100) | 12 (100) |
| BM infiltration by histopathology, N (%) | 12 (27.3) | 12 (54.5) | 2 (20) | 14 (100) | 12 (100) |
Abbreviations: Hb, hemoglobin; HSM, hepatosplenomegaly; LDH, lactate dehydrogenase; LNS, lymph nodes; N, number; SD, standard deviation.
Blood Res 2020;55:253~261 https://doi.org/10.5045/br.2020.2020070
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd